Additional file 1: Figure S1. of Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolution

Distribution of serum IL33 according to response to therapy. Serum IL33 levels at baseline and 6 months in responders (R) and non-responders (NR) in relation to therapy without significant differences (p > 0.05). Differences were assessed using Wilcoxon signed rank test. (TIFF 25551 kb)